Results 171 to 180 of about 197,418 (252)

[[alternative]]Doping--β[feaf] Agonist

, 2017
[[abstract]]β2致效劑（β2 agonist; β2作用劑）原本是用來治療氣喘的藥物，長期且大量服用有增加肌肉質量及降低脂肪的效果，尤其是促進快縮肌之生長，因此被許多運動員拿來濫用，以期能增進運動表現，然而其副作用及濫用所造成的嚴重後遺症，使得IOC將之列為運動禁藥。最新的IOC規定，係將同化性物質分為兩類：男性同化性類固醇（androgenic anabolic steroids）及β2致效劑（β2 agonist）。運動員開始使用同化性類固醇是在五十年代早期。當時蘇聯就有使用類固醇的報導。
何應志;許美智
core  

Long‐term effects of tofogliflozin on renal function in patients with type 2 diabetes: A retrospective multicenter study

Journal of Diabetes Investigation, EarlyView.
ABSTRACT Aims To investigate the long‐term renal effects of tofogliflozin, with the shortest half‐life among sodium–glucose cotransporter 2 inhibitors, in real‐world clinical practice. Materials and methods We retrospectively enrolled patients with type 2 diabetes mellitus treated at three affiliated hospitals between January 2015 and May 2024.
Natsuko Shinagawa, Hiroshi Okada, Junya Hironaka, Shinta Yamamoto, Mari Yoneda, Sayaka Kawai, Yuto Saijyo, Tomoya Katayama, Hanako Nakajima, Akio Kishi, Noriyuki Kitagawa, Naoko Nakanishi, Masahide Hamaguchi, Michiaki Fukui   +13 more
wiley   +1 more source

Predicting mortality with machine learning & biomarkers: A cohort analysis from aerosolized β₂-agonist for treatment of acute lung injury (ALTA) trial. [PDF]

Physiol Rep
Chase AM, Almuntashiri S, Zhang D, Jones TW, Chen X, Somanath PR, Henry K, Sikora A.   +7 more
europepmc   +1 more source

Short-acting β₂-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III. [PDF]

BMC Pulm Med, 2022
Yorgancıoğlu A, Aksu K, Naycı SA, Ediger D, Mungan D, Gül U, Beekman MJHI, SABINA Turkey Study Group.   +7 more
europepmc   +1 more source

Agonist-antagonist paired set resistance training: A brief review

, 2010
Agonist-antagonist paired set resistance training: A brief ...
WB Young (14539391), DG Behm (7774871), Warren Payne (13100226), DW Robbins (15787055)   +3 more
core  

A Pilot Placebo‐Controlled Randomized Trial of Repeated High‐Dose Intravenous Magnesium Sulphate and High‐Dose Nebulized Budesonide for Severe Asthma in the Paediatric Emergency Department

Journal of Paediatrics and Child Health, EarlyView.
ABSTRACT Objective Determine if high‐dose intravenous magnesium with/without nebulized budesonide for children with acute severe asthma is safe and reduces time to medical readiness for discharge compared to standard intravenous magnesium. Methods Either 2 doses of intravenous magnesium or 1 dose and placebo, each with/without high‐dose nebulized ...
Khalid Alansari, Fatin Abou Moussa, Hadi Abu Rasheed, Bruce L. Davidson, Khalid Yousif Ibrahim, Mahmoud Alrifaai   +5 more
wiley   +1 more source

Short-acting β₂-agonist use, exacerbation risk and triple therapy in COPD: <i>post hoc</i> analyses of ETHOS. [PDF]

ERJ Open Res
Hurst JR, Singh D, Martinez FJ, Rabe KF, Darken P, Arya N, Movitz C, Bowen K, Patel M.   +8 more
europepmc   +1 more source

Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β₂-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England. [PDF]

Int J Chron Obstruct Pulmon Dis, 2023
Czira A, Requena G, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS.   +12 more
europepmc   +1 more source

Innovations in Obesity Treatment: Beyond Adipose Tissue Dysfunction

Obesity Reviews, EarlyView.
Obesity drives chronic inflammation, insulin resistance, type 2 diabetes, and cancer development through adipocyte dysfunction. Addressing this multisystemic disorder requires integrated strategies beyond diet and exercise, such as thermogenesis activation via menthol or capsinoids and appetite control through GLP‐1/GIP agonists and neuromodulation to ...
Jesica Martínez‐Godfrey, Irene Pomares‐Bri, Paula de Juan‐Maciá, Mariló Olivares‐Vicente, Enrique Barrajón‐Catalán, Vicente Micol, Enrique Roche, María Herranz‐López   +7 more
wiley   +1 more source

A study protocol for a randomised controlled trial of two stepwise pharmacological treatment approaches to adult asthma: inhaled corticosteroid/formoterol reliever- <i>versus</i> short-acting β₂-agonist reliever-based therapy - Asthma on TRACK. [PDF]

ERJ Open Res
Sayers R, Cullen R, Oldfield K, Barrett J, Noble J, Eathorne A, Horne R, Weatherall M, Beasley R.   +8 more
europepmc   +1 more source